STATE STREET CORP - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$4,206,000
+52.7%
180,986
+4.6%
0.00%
Q1 2018$2,754,000
-13.4%
173,004
+13.0%
0.00%
Q4 2017$3,180,000
+44.8%
153,117
-0.1%
0.00%
Q3 2017$2,196,000
+47.9%
153,307
+78.7%
0.00%
Q2 2017$1,485,000
+42.1%
85,799
-9.4%
0.00%
Q1 2017$1,045,000
-40.9%
94,736
-22.2%
0.00%
Q4 2016$1,767,000
-50.4%
121,700
-16.2%
0.00%
Q3 2016$3,566,000
+9.6%
145,265
-10.1%
0.00%
Q2 2016$3,253,000
-2.4%
161,545
+27.5%
0.00%
Q1 2016$3,332,000
-69.0%
126,698
+19.9%
0.00%
-100.0%
Q4 2015$10,745,000
-3.5%
105,698
+69.3%
0.00%0.0%
Q3 2015$11,137,000
-34.7%
62,429
-18.7%
0.00%
-50.0%
Q2 2015$17,059,000
-6.9%
76,792
-16.7%
0.00%0.0%
Q1 2015$18,318,000
+37.5%
92,227
-1.0%
0.00%
+100.0%
Q4 2014$13,325,000
-23.9%
93,118
-30.2%
0.00%
-50.0%
Q3 2014$17,508,000
+113.8%
133,445
+105.6%
0.00%
+100.0%
Q2 2014$8,189,000
-57.7%
64,917
-55.8%
0.00%
-50.0%
Q1 2014$19,364,000
+220.9%
146,876
+104.9%
0.00%
Q4 2013$6,034,000
-89.5%
71,684
-87.0%
0.00%
-100.0%
Q3 2013$57,726,000
+2219.2%
553,310
+1813.9%
0.01%
Q2 2013$2,489,00028,9100.00%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2017
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders